The Drug Enforcement Administration is proposing to increase the registration and reregistration fees necessary to recover the costs of its Diversion Control Program relating to the registration and control of the importation, exportation, manufacture, distribution, and dispensing of controlled substances and list I chemicals. Comments are due no later than May 15.
The proposed amendments would increase registration fees for business activities involving controlled substances as well as list I chemicals and drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine, as follows.
- $3,699 (up from $3,047) for manufacturers of controlled substances or list I chemicals
- $1,850 (up from $1,523) for importers, exporters, distributors, and/or reverse distributors of controlled substances or list I chemicals
- $888 (up from $731) per three-year cycle for controlled substances business activities involving dispensing
- $296 (up from $244) per year for all other business activities of controlled substances (research, narcotic treatment programs, and chemical analysis)
This rule would also codify existing practices concerning when DEA will issue refunds for applicant registration fees.